Allurion Technologies Inc. (ALUR) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Allurion Technologies Inc. (ALUR:NYSE), powered by AI.

Current Price
$0.99
P/E Ratio
-0.3
Market Cap
7M
Sector
Healthcare
What is the Allurion Technologies Inc. stock price forecast?

Allurion Technologies Inc. is currently trading at $0.99. View real-time AI analysis on Alpha Lenz.

What is Allurion Technologies Inc. insider trading activity?

View the latest insider trading data for Allurion Technologies Inc. on Alpha Lenz.

What is Allurion Technologies Inc.'s P/E ratio?

Allurion Technologies Inc.'s P/E ratio is -0.3.

Allurion Technologies Inc.

NYSE · ALUR
$0.99+0.29(+41.43%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Allurion Technologies Inc.'s future dividend policy...
Alpha Chat Insight

Allurion Technologies Inc. trades at a P/E of -0.3 (undervalued) with strong ROE of 37.1%.

Ask for details

Company Overview

Allurion Technologies Inc. is a healthcare-focused company dedicated to developing non-invasive medical devices and technology solutions aimed at promoting weight loss and healthy living. The cornerstone of Allurion's offerings is the Elipse Balloon, a swallowable, intragastric balloon designed to aid in weight loss without the need for surgery or endoscopic procedures. This innovative device gradually inflates within the stomach, providing a temporary sense of fullness to patients, which helps reduce food intake. Allurion operates primarily within the medical technology and wellness sectors, targeting a global market that includes hospitals, clinics, and wellness centers. With obesity being a significant health concern worldwide, Allurion's non-surgical solutions garner attention for their potential impact on improving patient outcomes while reducing healthcare costs associated with obesity-related conditions. The company continues to evolve its technological platforms, incorporating digital tools to monitor and support patients throughout their weight loss journey, cementing its position in the intersection of health, technology, and consumer healthcare markets.

CEODr. Shantanu K. Gaur M.D.
SectorHealthcare
IndustryMedical Devices
Employees134

Company Statistics

FY 2025

Profile

$7.47MMarket Cap
$15.23MRevenue
0.00Shares Out
134Employees

Margins

62.84%Gross
-208.84%EBITDA
-198.01%Operating
-188.32%Pre-Tax
-188.81%Net

Valuation

-0.26P/E
-0.10P/B
0.49EV/Sales
-0.98EV/EBITDA
-0.26P/FCF

Growth (CAGR)

-38.10%Rev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-118.37%ROA
37.06%ROE
-118.07%ROIC

Financial Health

$5.41MCash & Cash Equivalents
$87.55MNet Debt
-120.43%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Allurion Technologies Inc. (ticker: ALUR) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 134 employees. Market cap is $7M.

The current price is $0.99 with a P/E ratio of -0.26x and P/B of -0.1x.

ROE is 37.06% and operating margin is -198.01%. Annual revenue is $15M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Allurion Technologies Inc. (ALUR) Stock Forecast 2026 $0.99 — Price, Financials & Analyst Targets | Alpha Lenz